Blood cancers remain a challenging group of diseases, with many types and subtypes. But we’ve made great strides in diagnosis and treatment, with additional, promising therapies on the way.
Top cancer care combines the latest advances with compassion and sensitivity - all delivered by doctors, nurses and support staff with the right experience. Our comprehensive approach gives you the support you need - from diagnosis to treatment and follow-up care.
Our treatments are research-backed and individualized, with the latest approaches for chemotherapy and radiation and a full range of newer targeted therapies. We also take part in some of the most promising research and clinical trials in the nation and offer the region’s largest stem cell transplant program.
For more information, please call our scheduling line.
202-444-2223
Meet The Team
Find a hematologist to meet your individual treatment needs.
Find a Clinical Trial
Offered through our research partnership with Georgetown Lombardi Comprehensive Cancer Center.
Lymphoma
Lymphoma refers to a group of white blood cell cancers in the lymphatic system — the part of the immune system that includes the lymph vessels, lymph nodes, spleen, thymus and tonsils. Learn more about lymphoma.
Targeted therapy continues to transform our breast cancer treatment, with the potential for more powerful and less toxic approaches. Also called immunotherapy or biological therapy, targeted therapy starts with the identification of a breast cancer’s particular characteristics.
Bone marrow or peripheral blood stem cell collection is the first step in your bone marrow or stem cell transplant process. At MedStar Georgetown University Hospital, we are home to the largest marrow and blood stem cell harvesting site for the National Marrow Donor Program.…
You may be wondering if you or a loved one is a good candidate for a transplantation procedure. Our transplant team will perform an extensive evaluation to determine if you are a suitable candidate for transplantation.
Blood cancers remain a challenging group of diseases, with many types and subtypes. But we’ve made great strides in diagnosis and treatment, with additional, promising therapies on the way.